search
Back to results

Amniotic Membrane in Carpal Tunnel Syndrome

Primary Purpose

Carpal Tunnel Syndrome

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Amniotic membrane transplantation
Sponsored by
Instituto de Oftalmología Fundación Conde de Valenciana
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Carpal Tunnel Syndrome focused on measuring Amniotic membrane transplantation

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with recent CTS diagnosis
  • Patients that undergo CTS surgery
  • Patients that accept to participate in the study
  • Patients that sign informed consent

Exclusion Criteria:

  • Patients with recurrent CTS diagnosis;
  • Patients with concomitant hand/arm comorbidities
  • Patients with any systemic disease that comprises muscles and bones
  • Collagenopathies
  • Systemic lupus erythematosus

Sites / Locations

  • Instituto de Oftalmología

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control

Experimental

Arm Description

The patients underwent conventional CTS surgery

The patients underwent conventional CTS surgery and transplantation of amniotic membrane

Outcomes

Primary Outcome Measures

BCTQ
The Boston Carpal Tunnel Questionnaire (BCTQ) is a disease-specific measure of self-reported symptom severity and functional status. It is frequently used in the reporting of outcomes from trials into interventions for carpal tunnel syndrome. It has two distinct scales, the Symptom Severity Scale (SSS) which has 11 questions and uses a five-point rating scale and the Functional Status Scale (FSS) containing 8 items which have to be rated for degree of difficulty on a five-point scale. Each scale generates a final score (sum of individual scores divided by number of items) which ranges from 1 to 5, with a higher score indicating greater disability.

Secondary Outcome Measures

Full Information

First Posted
August 28, 2019
Last Updated
August 29, 2019
Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Collaborators
National Council of Science and Technology, Mexico
search

1. Study Identification

Unique Protocol Identification Number
NCT04075357
Brief Title
Amniotic Membrane in Carpal Tunnel Syndrome
Official Title
Amniotic Membrane Transplantation for Carpal Tunnel Syndrome Treatment: One-year Follow-up
Study Type
Interventional

2. Study Status

Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
February 1, 2018 (Actual)
Primary Completion Date
July 21, 2019 (Actual)
Study Completion Date
August 28, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Collaborators
National Council of Science and Technology, Mexico

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Carpal Tunnel Syndrome (CTS) is the most frequent mononeuropathy. CTS is more frequent in females than in males, it has been associated to work activities, hormone exposure and obesity. Although its primary treatment is conservative, there is strong evidence that patients who retard surgery are more prone to develop worse outcomes. Surgery to treat CTS consists in liberating carpal tunnel in order to ameliorate median nerve symptoms; however, more than 20% of patients who undergo surgery have recurrent CTS (RCTS). RCTS is due to a fibrotic process in the site of the surgery. Amniotic membrane (AM) is the inner layer of the placenta which has been used to treat different pathologies. AM transplantation (AMT) has demonstrated to significantly inhibit inflammation and fibrosis. Therefore, the aim of the present study was to determine the effect of AMT in CTS surgery. The present is a randomized, open labeled, controlled clinical study. The investigators included patients with recent diagnosis of CTS and divided into two groups. The experimental group received AMT concomitantly with conventional surgery; whilst, the control group received only the conventional surgery. Clinical status of patients measured with the BCTQ questionaire was the main outcome. Both groups showed similar BCTQ punctuation at the beginning of the study. However, the results of the experimental group were significantly better than those from the control group through time, until the finish of the study. None of the patients presented complications or adverse effects related to the AMT. These results indicate that AMT is a secure and suitable treatment for CTS presenting better clinical outcomes at one-year follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carpal Tunnel Syndrome
Keywords
Amniotic membrane transplantation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
No Intervention
Arm Description
The patients underwent conventional CTS surgery
Arm Title
Experimental
Arm Type
Experimental
Arm Description
The patients underwent conventional CTS surgery and transplantation of amniotic membrane
Intervention Type
Other
Intervention Name(s)
Amniotic membrane transplantation
Intervention Description
Amniotic membrane was located over median nerve during surgery of CTS, prior of closing.
Primary Outcome Measure Information:
Title
BCTQ
Description
The Boston Carpal Tunnel Questionnaire (BCTQ) is a disease-specific measure of self-reported symptom severity and functional status. It is frequently used in the reporting of outcomes from trials into interventions for carpal tunnel syndrome. It has two distinct scales, the Symptom Severity Scale (SSS) which has 11 questions and uses a five-point rating scale and the Functional Status Scale (FSS) containing 8 items which have to be rated for degree of difficulty on a five-point scale. Each scale generates a final score (sum of individual scores divided by number of items) which ranges from 1 to 5, with a higher score indicating greater disability.
Time Frame
Through study completion, an average one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with recent CTS diagnosis Patients that undergo CTS surgery Patients that accept to participate in the study Patients that sign informed consent Exclusion Criteria: Patients with recurrent CTS diagnosis; Patients with concomitant hand/arm comorbidities Patients with any systemic disease that comprises muscles and bones Collagenopathies Systemic lupus erythematosus
Facility Information:
Facility Name
Instituto de Oftalmología
City
Mexico City
ZIP/Postal Code
06800
Country
Mexico

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Individual participant data will be published in a Journal. Therefore it will be supplied elsewhere.
Citations:
PubMed Identifier
32174033
Citation
Buentello-Volante B, Molina-Medinilla M, Aguayo-Flores E, Magana-Guerrero FS, Garfias Y. Comparison of amniotic membrane transplantation and carpal tunnel syndrome release surgery (CTRS) and CTRS alone: Clinical outcomes at 1-year follow-up. J Tissue Eng Regen Med. 2020 May;14(5):714-722. doi: 10.1002/term.3033. Epub 2020 Mar 24.
Results Reference
derived

Learn more about this trial

Amniotic Membrane in Carpal Tunnel Syndrome

We'll reach out to this number within 24 hrs